Visit WTR Logo
Subscribe now
Samsung settlement gives Xperi IP licensing revenue significant boost

InterDigital also announces fourth quarter results as company plots future growth from Technicolor acquisition

Samsung settlement gives Xperi IP licensing revenue significant boost
22 Feb 2019

Pharma still dominates in Israel, but Big Tech also likes what it sees

The Start-Up Nation is widely recognised for its contributions to the life sciences industries. However, patent analysis shows why global technology players are also going shopping there

22 Feb 2019

Japanese industry, government divided on patent reforms

Japan Inc is not on board with the JPO’s plans to boost damages and bring in new discovery procedures

Featured

21 Feb
2019

Burford takes aim at opioid overdose medication in series of IPRs

Reviews challenge validity of patents owned by Opiant Pharmaceuticals relating to Narcan brand of naloxone as price of treatments rises Read more

21 Feb
2019

As it awaits CAFC's TCL judgment, Ericsson secures vital win over HTC

Eastern District of Texas jury rules that patent royalty rates offered to the Taiwanese company were FRAND and that the comparable licensing model used to calculate them was correct Read more

21 Feb
2019

Startups from Southeast Asia have little to fear from IP but much to gain

At IPBC Southeast Asia, members of the region’s dynamic startup ecosystem heard that while IP may not yet be a critical threat to their business, it presents unique opportunities Read more

Most reads

1

Rolling the dice on eligibility

2

Giant NPE sold; the US’s first clean hands patent thicketing challenge; inside AT&T’s portfolio; why Huawei owns the future; and much more

3

PanOptis acquired by New York-based private equity business

4

Public consultation on biotech patent examination guidelines

5

Proposed patent linkages system sparks controversy

News

View all
20 Feb 2019

"4IR is all-encompassing" says Centrica IP chief ahead of IPBC Europe in Paris

Charles Clark, who has been with the energy multinational since 2016, talks strategy for a new industrial era in an exclusive interview with IAM in advance of the event, taking place at the end of March Read more

18 Feb 2019

Rolling the dice on eligibility

Congressional action is the only way to solve the uncertainty on section 101 of the US patent statute, argues Aaric Eisenstein of Personalised Media Communications Read more

18 Feb 2019

Patent deals show how Indian startups can benefit from multinational research activity

An AI health-tech startup recently named one of the world's most promising had its roots in the re-organisation of Xerox's research centre in India Read more

17 Feb 2019

Giant NPE sold; the US’s first clean hands patent thicketing challenge; inside AT&T’s portfolio; why Huawei owns the future; and much more

Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week - as well as links to each one Read more

Analysis

View all
19 Feb 2019

New Acacia chief IP officer charts a different course for the once mighty NPE

Supported by a healthy balance sheet, Marc Booth says the firm plans on a higher volume of smaller deals with three new areas identified for future growth Read more

19 Feb 2019

With Oppo deal, Ericsson gets crucial SEP validation in China

Securing a FRAND licence with the world’s fifth largest handset maker could be a shot in the arm for the Swedish company, which has struggled to get royalties out of Chinese firms like Xiaomi and TCL Read more

15 Feb 2019

PanOptis acquired by New York-based private equity business

The NPE, which bought Unwired Planet in 2016 and owns thousands of patents previously held by Ericsson and Panasonic, sold to Brevet Capital for an undisclosed sum Read more

15 Feb 2019

AbbVie’s Humira strategy to be scrutinised in first evergreening unclean hands challenge

In a Delaware case Boehringer Ingelheim accuses the Illinois company of improper conduct in deliberately constructing a patent thicket to protect against generic versions of its blockbuster drug. Read more

Events

View all
27-28 March
2019
Latest

IPBC Europe 2019

In the era of the fourth industrial revolution (4IR), European companies are faced with a number of exciting opportunities – but also significant IP challenges. Designed by and for European IP owners, the programme for IPBC Europe 2019 will explore how IP managers inside the continent’s businesses can devise and build sustainable value creation programmes in the rapidly changing world.

16-18 June
2019
Latest

IPBC Global 2019

The leading gathering of global IP decision makers and thought-leaders returns to Boston! As the fourth industrial revolution gathers pace, IPBC Global’s 2019 programme explores the key IP issues this new era of change and innovation presents for corporate leaders, policy makers, investors, the legal profession and third-party service providers.

Insights

30 Jan 2019

IP market news highlights

The big stories from the IAM platform in December and January. Read more

30 Jan 2019

Apple v Qualcomm is the global patent fight for our times

Why Qualcomm’s winning of an injunction in China against Apple is another sign that the patent market is drifting inexorably eastwards. With the country’s answer to the Court of Appeals for the Federal Circuit opening at the start of this year, rights holders have even more reason to turn to Chinese courts. Read more

30 Nov 2018

IP market news highlights

Some of the major stories carried on the IAM platform in October and November. Read more

30 Nov 2018

After years of setting the patent agenda Silicon Valley is now playing defence

The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative. Read more

Analysis

Latest analysis reports from IAM.

Thought leadership

IAM offers an extensive range of special reports.

Why subscribe?

Our unique and timely intelligence service informs commercial trademark decision making in boardrooms globally by translating trademark law into business sense.

Subscribe now
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.